Ligand validation:2GNU

LDA: LAURYL DIMETHYLAMINE-N-OXIDE

LDA is a Ligand Of Interest in 2GNU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GNU_LDA_H_1310	49%	32%	0.121	0.889	2.11	0.64	1	-	3	0	88%	0.875
3ZUW_LDA_M_1309	72%	16%	0.118	0.943	2.14	1.53	1	3	5	0	100%	1
5LSE_LDA_H_301	72%	6%	0.124	0.949	2.23	2.73	1	3	1	0	100%	1
3ZUM_LDA_L_702	67%	34%	0.125	0.933	1.95	0.7	1	-	6	0	100%	1
1RQK_LDA_H_901	65%	27%	0.14	0.941	2.15	0.81	1	-	1	0	100%	0.8
1RG5_LDA_H_901	64%	20%	0.145	0.943	1.91	1.46	1	2	0	0	100%	0.8
2VQI_LDA_B_1639	100%	35%	0.04	0.995	2.08	0.52	1	-	3	0	100%	1
6PRC_LDA_H_701	97%	23%	0.047	0.959	2.52	0.69	2	-	0	0	100%	1
3PRC_LDA_H_701	95%	24%	0.049	0.954	2.42	0.76	2	-	0	0	100%	1
2PRC_LDA_M_701	95%	25%	0.048	0.95	2.43	0.69	2	-	0	0	100%	1
5PRC_LDA_H_701	95%	20%	0.052	0.954	2.65	0.78	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.